Further research selectively targeting ATM genes confirmed their definitive role in obesity-associated metabolic disorders and inflammation by displaying an altered lipid and glucose metabolism as evidenced in lipoprotein lipase (LPL) and TNFα-depleted ATMs [18,19]. The gene discussed is LPL; the disease is Other metabolic disease.